PATENT CLAIM ANALYSIS

Application Number: 16340874
Application Type: Utility
Filing Date: 2019-04
Publication Date: 2019-08
Patent Classification: ["514", "264100"]

Abstract:
Novel MEK1, MEK2 and MEK1/2 inhibitors which have lower toxicity in long-term dosage, including the novel compound N-{3-[3-cyclopropyl-5-(2-fluoro-4-iodophenylamino)-6, 8-dimethyl-2,4,7-trioxo-3,4,6, 7-tetrahydro-2H-pyrido[4,3-d]pyrimidin-1-yl]-phenyl}-cyclopropanecarboxamide dimethyl sulfoxide solvate according to formula 1:

Claim (Index 23):
A method of preparing a compound according to  claim 12 , comprising treating a compound according to formula 2 or its salt, with cyclopropanecarboxylic acid or an activated derivative of cyclopropanecarboxylic acid

Metadata:
- Claim Count in Document: 2.0
- Percentile: 100.0
- Lexical Diversity: 1.11628
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['13499779', '14893746', '14197421', '13991576', '13699077']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.768044632294596
- 35 USC 102 Novelty (BERT): 0.5114121016440929
- Combined Prediction Score: 0.7423813792295457
- Mean Citation Score: 240.284514
- Max Citation Score: 263.9812
- Similarity Product: 166.40366319055556

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test